interleukin 12A
| GO Term | Evidence Code | PMID |
|---|---|---|
| positive regulation of T cell mediated cytotoxicity | ||
| positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | ||
| immune response | ||
| response to virus | ||
| response to UV-B |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular space | ||
| endoplasmic reticulum lumen | ||
| late endosome lumen | ||
| interleukin-12 complex |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytokine activity | ||
| cytokine activity | ||
| cytokine activity | ||
| interleukin-12 receptor binding | ||
| interleukin-12 receptor binding |
| Gene Ontology |
|---|
| cytokine activity |
| growth factor activity |
| immune response |
| interleukin-12 receptor binding |
| InterPro |
|---|
| Four-helical cytokine-like, core |
| Interleukin-12 alpha |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:12236 | primary biliary cholangitis | |
| DOID:1883 | hepatitis C | |
| DOID:684 | hepatocellular carcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026